{"id":1672,"date":"2021-02-18T07:00:00","date_gmt":"2021-02-18T07:00:00","guid":{"rendered":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-bokslutskommunike-2020\/"},"modified":"2024-08-06T12:25:13","modified_gmt":"2024-08-06T12:25:13","slug":"acarix-ab-publ-publicerar-bokslutskommunike-2020","status":"publish","type":"post","link":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-bokslutskommunike-2020\/","title":{"rendered":"Acarix AB (publ) publicerar Bokslutskommunik\u00e9 2020"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong><\/strong><\/div>\n<div>\n<p>Press release (MAR)<\/p>\n<p>Malm\u00f6, 18 februari, 2021<\/p>\n<p><strong>Acarix AB (publ) publicerar Bokslutskommunik\u00e9 2020<\/strong><\/p>\n<p><strong>Ett starkt avslut p\u00e5 ett h\u00e4ndelserikt \u00e5r<\/strong><\/p>\n<p>Det fj\u00e4rde kvartalet bidrog starkt till v\u00e5r utveckling under 2020, med marknadsgodk\u00e4nnandet f\u00f6r CADScor\u00ae fr\u00e5n det amerikanska l\u00e4kemedelsverket US Food and Drug Administration (FDA), som kronan p\u00e5 verket.<\/p>\n<p><em>Utdrag ur VD Per Perssons kommentar till del\u00e5rsrapporten.<\/em><\/p>\n<p><strong>Fj\u00e4rde kvartalet 2020 j\u00e4mf\u00f6rt med samma period 2019<\/strong><\/p>\n<ul type=\"disc\">\n<li>Under fj\u00e4rde kvartalet s\u00e5ldes 22 (10, varav 4 till kliniska pr\u00f6vningar) CADScor\u00aeSystem och 1\u00a0420 (1\u00a0500, varav 840 till kliniska pr\u00f6vningar) eng\u00e5ngspl\u00e5ster till b\u00e5de slutf\u00f6rbrukare och distribut\u00f6rer.<\/li>\n<li>Int\u00e4kterna uppgick till 966 kSEK (774), med ett bruttoresultat om 713 kSEK (607) och en bruttomarginal om 74 procent (78).<\/li>\n<li>R\u00f6relsekostnaderna uppgick till 12\u00a0100 kSEK (10\u00a0591).<\/li>\n<li>Resultat f\u00f6re skatt uppgick till \u201311\u00a0411 kSEK (\u20139\u00a0987).<\/li>\n<li>Kassafl\u00f6det fr\u00e5n den l\u00f6pande verksamheten uppgick till \u201312\u00a0546 kSEK (\u20138\u00a0122). Periodens nettokassafl\u00f6de uppgick till \u201312\u00a0034 (26\u00a0037) kSEK.<\/li>\n<li>Resultat per aktie uppgick till \u20130,08 SEK (\u20130,31). Inga utsp\u00e4dningseffekter uppkom.<\/li>\n<\/ul>\n<p><strong>R\u00e4kenskaps\u00e5ret 2020 j\u00e4mf\u00f6rt med 2019<\/strong><\/p>\n<ul type=\"disc\">\n<li>Under \u00e5ret s\u00e5ldes totalt 51 (23, varav 5 till kliniska pr\u00f6vningar) CADScor\u00aeSystem, och 3\u00a0540 (4\u00a0326, varav 2\u00a0040 till kliniska pr\u00f6vningar) eng\u00e5ngspl\u00e5ster. Totalt f\u00f6r \u00e5ret genererades int\u00e4kter p\u00e5 2\u00a0170 kSEK (1\u00a0857) med ett brutto-resultat om 1\u00a0594 kSEK (1\u00a0430), motsvarande en brutto-marginal p\u00e5 73 procent (77).<\/li>\n<li>R\u00f6relsekostnaderna uppgick till 43\u00a0025 kSEK (47\u00a0873).<\/li>\n<li>Resultat f\u00f6re skatt uppgick till \u201341\u00a0496 kSEK (\u201346\u00a0434).<\/li>\n<li>Kassafl\u00f6det fr\u00e5n den l\u00f6pande verksamheten uppgick till \u201336\u00a0686 kSEK (\u201344\u00a0533). Periodens nettokassafl\u00f6de till 10\u00a0663 kSEK (\u201311\u00a0500).<\/li>\n<li>Beh\u00e5llning av likvida medel uppgick till 64\u00a0113 kSEK (53\u00a0747).<\/li>\n<li>Resultat per aktie uppgick till \u20130,51 SEK (\u20131,83). Inga utsp\u00e4dningseffekter uppkom.<\/li>\n<\/ul>\n<p><strong>H\u00e4ndelser under fj\u00e4rde kvartalet 2020<\/strong><\/p>\n<ul type=\"disc\">\n<li>Den 15 oktober har bolaget ing\u00e5tt avtal med Redeye AB avseende tj\u00e4nsten som Certified Adviser. Redeye AB tilltr\u00e4dde som Certified Adviser den 19 oktober 2020<\/li>\n<li>Den 18 november meddelade Acarix att bolagets analys av reell anv\u00e4ndning av CADScor\u00aeSystem, gjord i samarbete med kliniker i Tyskland och \u00d6sterrike, presenteras som en poster p\u00e5 ISPOR, den ledande europeiska konferensen f\u00f6r h\u00e4lsoekonomi och utfallsforskning, som h\u00e5lls virtuellt den 16-19 november 2020.Analysen av patientdata visar att varken patientdemografi eller testresultat skiljer sig n\u00e4mnv\u00e4rt fr\u00e5n de studiebaserade resultaten fr\u00e5n DanNICAD\u00a01 och att verkliga data d\u00e4rmed kan anv\u00e4ndas f\u00f6r ytterligare ekonomisk modellering.<\/li>\n<li>Den 25 november meddelande bolaget att det amerikanska l\u00e4kemedelsverket (FDA) har godk\u00e4nt bolagets De Novo ans\u00f6kan f\u00f6r ett marknadsf\u00f6ringsgodk\u00e4nnande f\u00f6r CADScor\u00aeSystem i USA. \u201dDetta \u00e4r en fenomenal prestation och ett enormt erk\u00e4nnande av v\u00e5r teknologi och CADScor\u00aeSystems m\u00f6jlighet att f\u00f6rb\u00e4ttra den diagnostiska processen f\u00f6r potentiella CAD-patienter i USA.\u201d s\u00e4ger Per Persson, vd f\u00f6r Acarix.<\/li>\n<li>Den 9 december meddelade bolaget att den sista patienten har inkluderats i Dan-NICAD II studien. Dan-NICAD\u00a0II studien som omfattar data fr\u00e5n sammanlagt 1\u00a0726 patienter inleddes i januari 2018 med syfte att ytterligare bef\u00e4sta den diagnostiska noggrannheten f\u00f6r CADScor\u00aeSystemet j\u00e4mf\u00f6rt med andra stratifieringsalternativ tillg\u00e4ngliga idag. Dan-NICAD\u00a0II studien har \u00e4ven omfattat patienter p\u00e5 under 40 \u00e5r, vilket \u00f6ppnar upp f\u00f6r en m\u00f6jlig breddning av den idag g\u00e4llande patientgruppen och som i slut\u00e4ndan skulle kunna inneb\u00e4ra att CADScor\u00aeSystem kan anv\u00e4ndas p\u00e5 patienter vid 30 \u00e5rs \u00e5lder.<\/li>\n<\/ul>\n<p><strong>H\u00e4ndelser efter den 31 december 2020<\/strong><br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00b7Den 13 januari meddelade bolaget positiva prelimin\u00e4ra data fr\u00e5n den unders\u00f6kande SEISMO-studien som g\u00f6rs med modifierade CADScor\u00aeSystem f\u00f6r en potentiell hj\u00e4rtsviktstill\u00e4mpning. SEISMO-studien inleddes i juni 2018 f\u00f6r att utv\u00e4rdera m\u00f6jligheten att utveckla en algoritm som kan skilja patienter som h\u00e4nvisas med misstankar om hj\u00e4rtsvikt. Studien, med totalt 199 patienter p\u00e5 tv\u00e5 platser i Danmark, inkluderade den sista patienten 2020. \u201dAtt slutf\u00f6ra inkluderingen i den unders\u00f6kande hj\u00e4rtsviktstudien var en stor milstolpe f\u00f6r alla inblandade. Dessa nya data ser lovande ut f\u00f6r att tidigt kunna utesluta hj\u00e4rtsvikt och kommer att vara viktiga f\u00f6r alla drabbade patienter som idag v\u00e4ntar alltf\u00f6r l\u00e4nge p\u00e5 en slutlig diagnos. Dessa prelimin\u00e4ra data kan motivera en uppf\u00f6ljningsstudie f\u00f6r att konsolidera resultaten och f\u00e5 mer data f\u00f6r algoritmutveckling\u201d, s\u00e4ger professor Peter S\u00f8gaard, l\u00e4kare och huvudpr\u00f6vare. Resultaten fr\u00e5n den slutliga analysen av studiedata f\u00f6rv\u00e4ntas l\u00e4mnas f\u00f6r publicering under andra kvartalet 2021.<\/p>\n<p>Den fullst\u00e4ndiga del\u00e5rsrapporten finns tillg\u00e4nglig via l\u00e4nk nedan samt p\u00e5 www.acarix.com<\/p>\n<p><strong>Kontaktpersoner f\u00f6r mer information <\/strong><\/p>\n<p>Per Persson, VD <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=f9VxRezwN7-LLlLSjqkbNX5YErittpxuqSPpM0tvDGwp2j9G0STb2FI_Az7cylv0qI71He9kbHIuyOPU-V9BRtGW1danWAJrPkMcbJyL2BE=\" target=\"_blank\" title=\"\" rel=\"nofollow noopener\"><u>per.persson@acarix.com<\/u><\/a> <br \/>+46 736 005\u00a0990<\/p>\n<p>Christian Lindholm, CFO <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0yNnAwLb8gC_g6hFf81bT6sjaiICZahuFtC0j6M4Jn_n5LSsJlTWSgj-XDtdZYJts3YHpAvFjHpSO4GKvqx4xA1uIhPajDUL0cT3ZqumGCD18XgCiZLRCXfbt523H5rp\" target=\"_blank\" title=\"\" rel=\"nofollow noopener\"><u>christian.lindholm@acarix.com<\/u><\/a><br \/>+46 705 118\u00a0333<\/p>\n<p><strong>Om Acarix<\/strong><br \/>Acarix grundades 2009 och \u00e4r noterat p\u00e5 Nasdaq First North Premier. Acarix CADScor\u00aeSystem anv\u00e4nder en avancerad sensor som placeras p\u00e5 huden ovanf\u00f6r hj\u00e4rtat f\u00f6r att lyssna p\u00e5 ljudet av hj\u00e4rtkontraktion och turbulent fl\u00f6de. Det har utformats f\u00f6r att vara ett allt-i-ett-system i den meningen att signalen fr\u00e5n hj\u00e4rtat spelas in, bearbetas och visas som en patientspecifik s.k. CAD-score p\u00e5 sk\u00e4rmen. Presentation av m\u00e4tresultaten erh\u00e5lls p\u00e5 mindre \u00e4n 8 minuter. Som en s\u00e4ker metod och l\u00e4mplig f\u00f6r anv\u00e4ndning i b\u00e5de prim\u00e4rv\u00e5rden och p\u00e5 inneliggande patienter kan CADScor\u00aeSystem potentiellt komma att spela en viktig roll f\u00f6r patient-triage, n\u00e5got som g\u00f6r att m\u00e5nga patienter inte beh\u00f6ver unders\u00f6kas ytterligare med invasiva, diagnostiska metoder. <br \/> Redeye AB \u00e4r bolagets Certified Advisor (+46 (0)8 121 576 90, (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=71VkLZNGSaWoUwPLEkPRcNxjVzpAmhSkdjdE_Dhbm9RsUF_P5EZmu5ZCrfdf6WYOw71_HrImo9xY39WpaDZ82_oKqXiL6FANN1A5gpVvv4IVcSKjBU3gaUD_M6PuJ04N\" target=\"_blank\" rel=\"nofollow noopener\">certifiedadviser@redeye.se<\/a>). <br \/> F\u00f6r mer information bes\u00f6k www.acarix.com.<\/p>\n<p><em>Denna <\/em><em>information <\/em><em>\u00e4r regulatorisk information som Acarix AB (publ)<\/em> <em>ska offentligg\u00f6ra enligt EU:s marknadsmissbruksf\u00f6rordning.<\/em> <em>Informationen l\u00e4mnades f\u00f6r publicering genom ovanst\u00e5ende kontaktpersons f\u00f6rsorg den 18 februari 2021 kl 08.00.<\/em><\/p>\n<\/p>\n<p><\/div>\n<div class=\"mfn-footer mfn-attachment\">\n<p><strong>Bifogade filer<\/strong><\/p>\n<hr\/>\n<p><a href=\"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2024\/08\/c77fe4ab-71c1-4fcd-b27d-f39b58cf815c.pdf\" target=\"_blank\" rel=\"nofollow noopener\">Acarix Bokslutskommunike Q4 2020_Final<\/a><br \/><a href=\"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2024\/08\/f88e5430-7ea2-4ba1-ae66-bba89f821649.pdf\" target=\"_blank\" rel=\"nofollow noopener\">PM_Acarix_Bokslutskommunik\u00e9_2020 sv<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer\"><\/div>\n<script>\n                Array.prototype.slice.call(document.querySelectorAll(\".mfn-footer.mfn-attachment\")).forEach(function (el) { el.remove() });\n            <\/script>\n        <div class=\"mfn-attachments-container\"><\/div>","protected":false},"excerpt":{"rendered":"<p>Press release (MAR) Malm\u00f6, 18 februari, 2021 Acarix AB (publ) publicerar Bokslutskommunik\u00e9 2020 Ett starkt avslut p\u00e5 ett h\u00e4ndelserikt \u00e5r<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[59],"tags":[62,63,70,71,75],"class_list":["post-1672","post","type-post","status-publish","format-standard","hentry","category-press","tag-regulatory","tag-regulatorymar","tag-subreport","tag-subreportinterim","tag-subreportinterimq4"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Acarix AB (publ) publicerar Bokslutskommunik\u00e9 2020 - Acarix<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Acarix AB (publ) publicerar Bokslutskommunik\u00e9 2020 - Acarix\" \/>\n<meta property=\"og:description\" content=\"Press release (MAR) Malm\u00f6, 18 februari, 2021 Acarix AB (publ) publicerar Bokslutskommunik\u00e9 2020 Ett starkt avslut p\u00e5 ett h\u00e4ndelserikt \u00e5r\" \/>\n<meta property=\"og:url\" content=\"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-bokslutskommunike-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"Acarix\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-18T07:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-06T12:25:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2026\/02\/Acarix_web_image.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"673\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"acarix\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"acarix\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-bokslutskommunike-2020\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-bokslutskommunike-2020\\\/\"},\"author\":{\"name\":\"acarix\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#\\\/schema\\\/person\\\/dac8bcb35fc08033de2c787d232971b5\"},\"headline\":\"Acarix AB (publ) publicerar Bokslutskommunik\u00e9 2020\",\"datePublished\":\"2021-02-18T07:00:00+00:00\",\"dateModified\":\"2024-08-06T12:25:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-bokslutskommunike-2020\\\/\"},\"wordCount\":939,\"keywords\":[\":regulatory\",\":regulatory:mar\",\"sub:report\",\"sub:report:interim\",\"sub:report:interim:q4\"],\"articleSection\":[\"Press\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-bokslutskommunike-2020\\\/\",\"url\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-bokslutskommunike-2020\\\/\",\"name\":\"Acarix AB (publ) publicerar Bokslutskommunik\u00e9 2020 - Acarix\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#website\"},\"datePublished\":\"2021-02-18T07:00:00+00:00\",\"dateModified\":\"2024-08-06T12:25:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#\\\/schema\\\/person\\\/dac8bcb35fc08033de2c787d232971b5\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-bokslutskommunike-2020\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-bokslutskommunike-2020\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-bokslutskommunike-2020\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Acarix AB (publ) publicerar Bokslutskommunik\u00e9 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#website\",\"url\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/\",\"name\":\"Acarix\",\"description\":\"CADScor\u00aeSystem\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#\\\/schema\\\/person\\\/dac8bcb35fc08033de2c787d232971b5\",\"name\":\"acarix\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/wp-content\\\/plugins\\\/userswp\\\/assets\\\/images\\\/no_profile.png\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/wp-content\\\/plugins\\\/userswp\\\/assets\\\/images\\\/no_profile.png\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/wp-content\\\/plugins\\\/userswp\\\/assets\\\/images\\\/no_profile.png\",\"caption\":\"acarix\"},\"sameAs\":[\"https:\\\/\\\/www.acarix.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Acarix AB (publ) publicerar Bokslutskommunik\u00e9 2020 - Acarix","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Acarix AB (publ) publicerar Bokslutskommunik\u00e9 2020 - Acarix","og_description":"Press release (MAR) Malm\u00f6, 18 februari, 2021 Acarix AB (publ) publicerar Bokslutskommunik\u00e9 2020 Ett starkt avslut p\u00e5 ett h\u00e4ndelserikt \u00e5r","og_url":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-bokslutskommunike-2020\/","og_site_name":"Acarix","article_published_time":"2021-02-18T07:00:00+00:00","article_modified_time":"2024-08-06T12:25:13+00:00","og_image":[{"width":1200,"height":673,"url":"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2026\/02\/Acarix_web_image.webp","type":"image\/webp"}],"author":"acarix","twitter_card":"summary_large_image","twitter_misc":{"Written by":"acarix","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-bokslutskommunike-2020\/#article","isPartOf":{"@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-bokslutskommunike-2020\/"},"author":{"name":"acarix","@id":"https:\/\/d.ptpl.dev\/acarix\/#\/schema\/person\/dac8bcb35fc08033de2c787d232971b5"},"headline":"Acarix AB (publ) publicerar Bokslutskommunik\u00e9 2020","datePublished":"2021-02-18T07:00:00+00:00","dateModified":"2024-08-06T12:25:13+00:00","mainEntityOfPage":{"@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-bokslutskommunike-2020\/"},"wordCount":939,"keywords":[":regulatory",":regulatory:mar","sub:report","sub:report:interim","sub:report:interim:q4"],"articleSection":["Press"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-bokslutskommunike-2020\/","url":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-bokslutskommunike-2020\/","name":"Acarix AB (publ) publicerar Bokslutskommunik\u00e9 2020 - Acarix","isPartOf":{"@id":"https:\/\/d.ptpl.dev\/acarix\/#website"},"datePublished":"2021-02-18T07:00:00+00:00","dateModified":"2024-08-06T12:25:13+00:00","author":{"@id":"https:\/\/d.ptpl.dev\/acarix\/#\/schema\/person\/dac8bcb35fc08033de2c787d232971b5"},"breadcrumb":{"@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-bokslutskommunike-2020\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-bokslutskommunike-2020\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-bokslutskommunike-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/d.ptpl.dev\/acarix\/"},{"@type":"ListItem","position":2,"name":"Acarix AB (publ) publicerar Bokslutskommunik\u00e9 2020"}]},{"@type":"WebSite","@id":"https:\/\/d.ptpl.dev\/acarix\/#website","url":"https:\/\/d.ptpl.dev\/acarix\/","name":"Acarix","description":"CADScor\u00aeSystem","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/d.ptpl.dev\/acarix\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/d.ptpl.dev\/acarix\/#\/schema\/person\/dac8bcb35fc08033de2c787d232971b5","name":"acarix","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\/\/d.ptpl.dev\/acarix\/wp-content\/plugins\/userswp\/assets\/images\/no_profile.png","url":"https:\/\/secure.gravatar.com\/avatar\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\/\/d.ptpl.dev\/acarix\/wp-content\/plugins\/userswp\/assets\/images\/no_profile.png","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\/\/d.ptpl.dev\/acarix\/wp-content\/plugins\/userswp\/assets\/images\/no_profile.png","caption":"acarix"},"sameAs":["https:\/\/www.acarix.com"]}]}},"_links":{"self":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts\/1672","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/comments?post=1672"}],"version-history":[{"count":0,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts\/1672\/revisions"}],"wp:attachment":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/media?parent=1672"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/categories?post=1672"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/tags?post=1672"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}